In last trading session, Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) saw 2.26 million shares changing hands with its beta currently measuring 0.26. Company’s recent per share price level of $2.38 trading at $0.11 or 4.85% at ring of the bell on the day assigns it a market valuation of $606.09M. That closing price of MRVI’s stock is at a discount of -321.43% from its 52-week high price of $10.03 and is indicating a premium of 30.25% from its 52-week low price of $1.66. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.67 million shares which gives us an average trading volume of 2.01 million if we extend that period to 3-months.
For Maravai LifeSciences Holdings Inc (MRVI), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.92. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) trade information
Upright in the green during last session for gaining 4.85%, in the last five days MRVI remained trading in the green while hitting it’s week-highest on Thursday, 06/26/25 when the stock touched $2.38 price level, adding 2.46% to its value on the day. Maravai LifeSciences Holdings Inc’s shares saw a change of -66.34% in year-to-date performance and have moved 18.41% in past 5-day. Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) showed a performance of 6.73% in past 30-days. Number of shares sold short was 13.05 million shares which calculate 7.4 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 5 to the stock, which implies a rise of 52.4% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 5. It follows that stock’s current price would drop -110.08% in reaching the projected high whereas dropping to the targeted low would mean a loss of -110.08% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -64.27% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -182.64% while estimates for its earnings growth in next 5 years are of -29.53%.
Maravai LifeSciences Holdings Inc (NASDAQ:MRVI)’s Major holders
Insiders are in possession of 9.93% of company’s total shares while institution are holding 89.93 percent of that, with stock having share float percentage of 99.84%. Investors also watch the number of corporate investors in a company very closely, which is 89.93% institutions for Maravai LifeSciences Holdings Inc that are currently holding shares of the company. GTCR LLC is the top institutional holder at MRVI for having 20.15 million shares of worth $144.27 million. And as of 2024-06-30, it was holding 14.8334 of the company’s outstanding shares.
The second largest institutional holder is 12 WEST CAPITAL MANAGEMENT LP, which was holding about 13.21 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.7254 of outstanding shares, having a total worth of $94.59 million.
